Paid Clinical Trials - 82,000 Members & Growing

  • Paid Clinical Trials
  • About Us
  • Auto-Updates
  • FAQ's
  • Quick Start Guide
www.GlobalTestMarket.com

 

Find Paid Clinical Trials Join Paid Clinical Trials ...

PaidClinicalTrials.org is a registry of compensated and uncompensated, federally and privately supported clinical trials conducted in the United States and around the world. Here you will find information about a trial's purpose, who may participate, locations, and phone numbers.

 

Find Paid Clinical Trials Clinical Trial Seekers - PCT is a public service, sponsor supported, clinical trial database that may be accessed by the general public at no charge in accordance with our terms of service use.

Clinical trials are added and removed each day on a 30 day rotation. For accuracy - We only list clinical trials that have been reported to these government agencies in the last 30 days:

 

U.S. National Library of Medicine,
U.S. Department of Health & Human Services
U.S. National Institutes of health Services.







Paid Clinical Trials - Auto Update Service

If you would like to receive timely and important notifications about new clinical trials in your area please fill out this short form. There is never any cost for our notification services. We value your privacy, your email address and member information is NEVER shared!

*  Your Email Address:
*  Preferred Format:
    Title:
    First Name:
    Country:
    State (US):
    City (UK):
    Territory (AU):

Tips for Finding Clinical Trials

 

One of the toughest and most-time consuming parts for medical research staff conducting the clinical trials is actually finding volunteers willing to participate. Research staff are looking for you! There are numerous ways to identify clinical trials looking for healthy human volunteers.

 

Trials are actively conducted by hospitals, universities, foundations, and contract research organizations (CROs, firms that conduct studies for big pharmaceutical and biotechnology companies). According to CISCRP, nearly 40% of these clinical trials can be learned about through media such as tv, radio, or printed ads. While finding studies through tv and radio ads might be difficult, you can actively scour the wanted section of your local newspapers to find trials.

Most local research clinics run ads for volunteers in the local newspaper, employment papers, on TV, and on the radio. They also post ads on Craigslist and on their own websites. Call them up as soon as you see something of interest. If the study is no longer recruiting volunteers, they might enter you in there database for future study participation.

 

Look up local research clinics in your phone book and ask (a) if they have any studies openly recruiting healthy volunteers and (b) if you could be entered into their volunteer database.

College campuses and major universities with research hospitals are also great places to find clinical trial. Schools of medicine, dentistry, and nursing, along with departments of psychology, sociology, and communications, at local universities, are always looking for willing volunteers for their experiments. Perform an internet search for the hospitals, schools, and departments on nearby campuses, then look for any section concerning clinical trials or research volunteers.


When searching for clinical trials on our website you will click on a Clinical Trial Information sheet like this example. Find Paid Clinical Trials Example Information Sheet. The first thing you should do is to see if the clinical trial is right for you. You can do this by quickly scanning the headings of the information sheet. These headings are highlighted on the left by blue icons as follows:


  >> Status of the Clinical Trial (This will appear at the top in red or green)


Purpose - This will briefly let you know about the clinical trial and how it is conducted.


Eligibility - This tells you age, gender and health status information. If you do not meet these eligibility requirement you should move to another clinical trial.


Contacts and Locations - This will list the locations the clinical trial is being conducted and it will usually list the contact person to call. Note - Even if your location is not listed you should call the clinical trial investigator. Sometimes their locations have not been updated or they are willing to pay time and travel expenses.


More Information - This will often give alternative contact people and other pertinent information about the trial.

These headings appear on the left side of the information sheet and are fairly self explanatory. Doing this will help you to quickly evaluate if the clinical trial is right for you.

 


 

Paid Clinical Trials Searching Tips

 

Paid Clinical Trials Check the Conditions Category - If you only search the "Locations" directory you are missing out on a lot of clinical trials. Trials that are listed by "Condition" usually have multiple locations and can add new locations as the study moves forward.

 

Paid Clinical Trials Register Your Profile with us. - You can post your location and condition in our personal clinical trials directory for FREE. This helps the research recruiters find you when the right trial becomes available. Register for Clinical Trials Here.

 

Paid Clinical Trials Call the Clinical Trial Recruiters - At the bottom of all the information sheets you will see a "Contact Information" heading. Many clinical trials can be conducted in remote locations and the recruiters can help you.

 

Paid Clinical Trials Subscribe to our Auto Update Service - By subscribing to our Auto Update Service you will receive automated emails informing you when new trials have opened in your area.

Sponsored Links







  • Condition:   Alcohol Dependence
    Interventions:   Procedure: Advanced Nurse (AN);   Procedure: General Practitioner (GP)
    Sponsors:   University Hospital, Lille;   Ministry of Health, France
    Recruiting - verified February 2017

  • Condition:   Alcoholism
    Interventions:   Behavioral: Retrieval-Extinction Learning;   Other: rTMS;   Other: SAM
    Sponsors:   Hospital Universitario 12 de Octubre;   Ministerio de Sanidad, Servicios Sociales e Igualdad
    Recruiting - verified February 2017

  • Conditions:   Alcohol Use Disorder;   Anxiety Disorder/Anxiety State;   Stress Disorder;   HPA;   Drinking to Cope
    Intervention:  
    Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified February 2017

  • Conditions:   Alcohol Use Disorder;   Critically Ill
    Intervention:   Behavioral: Brief intervention
    Sponsor:   Helsinki University
    Not yet recruiting - verified February 2017

  • Condition:   Alcohol Use
    Interventions:   Drug: Oxytocin;   Drug: Placebo
    Sponsor:   Medical University of South Carolina
    Not yet recruiting - verified February 2017

  • Condition:   Alcohol-Related Disorders
    Interventions:   Other: Melatonin;   Other: Placebo
    Sponsor:   Centre for Addiction and Mental Health
    Recruiting - verified February 2017

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Varenicline;   Drug: Placebo oral capsule
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified January 2017

  • Condition:   Alcohol Use Disorder
    Interventions:   Other: [11C]-(+)-PHNO PET scan;   Other: Alcohol Self-Administration;   Other: Craving Task;   Other: MRI scan;   Other: Neuropsychological Assessment
    Sponsor:   Centre for Addiction and Mental Health
    Recruiting - verified January 2017

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Topiramate;   Drug: placebo
    Sponsor:   VA Office of Research and Development
    Not yet recruiting - verified January 2017

  • Conditions:   Liver Fibroses;   Alcohol-Induced Disorders
    Intervention:   Other: Ethanol
    Sponsor:   Odense University Hospital
    Recruiting - verified January 2017

  • Conditions:   Cocaine Addiction;   Alcohol Addiction
    Interventions:   Drug: Alcohol N-acetylcysteine;   Drug: Alcohol Placebo;   Drug: Cocaine N-acetylcysteine;   Drug: Cocaine Placebo
    Sponsors:   Hospital de Clinicas de Porto Alegre;   Secretaria Nacional de Políticas sobre Drogas (SENAD)
    Recruiting - verified January 2017

  • Condition:   Antisocial Behavior
    Interventions:   Behavioral: Multisystemic Therapy-Emerging Adults;   Behavioral: Enhanced Treatment as Usual
    Sponsors:   Oregon Social Learning Center;   University of Massachusetts, Worcester
    Not yet recruiting - verified January 2017

  • Condition:   Alcohol Withdrawal Syndrome
    Interventions:   Drug: Magnesium;   Drug: Placebo Oral Tablet
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   Ministry of Health, France
    Not yet recruiting - verified January 2017

  • Condition:   Alcohol Withdrawal Syndrome
    Interventions:   Drug: Gabapentin;   Drug: Benzodiazepines;   Drug: Divalproex Sodium
    Sponsor:   Mayo Clinic
    Recruiting - verified February 2017

  • Condition:   Alcohol Dependence
    Interventions:   Drug: Fish Oil with ethanol and placebo ethanol infusions;   Drug: Placebo with ethanol and placebo ethanol infusions
    Sponsors:   Yale University;   VA Connecticut Healthcare System
    Not yet recruiting - verified January 2017

  • Conditions:   Smoking Cessation;   Alcohol Drinking
    Interventions:   Drug: Nicotine Replacement Therapy;   Drug: Bupropion;   Behavioral: Cognitive Behavioral Treatment;   Behavioral: Mobile Contingency Management
    Sponsor:   Duke University
    Recruiting - verified November 2016

  • Condition:   Alcohol Use Disorder
    Interventions:   Behavioral: Mindfulness Plus Relapse Prevention Therapy;   Behavioral: Relapse Prevention Therapy
    Sponsors:   University of Colorado, Boulder;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Conditions:   Alcohol Drinking;   Cigarette Smoking Toxicity
    Intervention:   Drug: Reduced nicotine cigarettes
    Sponsor:   Battelle Memorial Institute
    Not yet recruiting - verified December 2016

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Mifepristone;   Drug: CORT125134;   Drug: Placebo - Cap
    Sponsors:   Johns Hopkins University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Condition:   Alcohol Abuse
    Interventions:   Behavioral: Brief Advice;   Behavioral: NIAAA Clinician's Guide;   Behavioral: Motivational Interviewing (MI)
    Sponsors:   University of New Mexico;   National Institutes of Health (NIH);   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 2016

  • Conditions:   Alcohol Drinking;   Marijuana
    Interventions:   Drug: THC 7.2%;   Drug: THC 3.0%;   Drug: Placebo
    Sponsors:   Brown University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified January 2017

  • Condition:   Alcohol-Related Disorders
    Intervention:   Behavioral: Implementation program
    Sponsors:   Agrupamento de Centros de Saúde de Dão Lafões;   University of Cambridge
    Recruiting - verified November 2016

  • Condition:   Alcohol Abuse
    Interventions:   Behavioral: eHealth Coping Skills Training;   Behavioral: eHealth Usual Web Care;   Behavioral: Coach Support
    Sponsors:   State University of New York at Buffalo;   University of Oregon
    Not yet recruiting - verified December 2016

  • Condition:   Alcohol Dependence
    Interventions:   Behavioral: Alc-IT (50/50) (morning);   Behavioral: Alc-IT (75/25) (morning);   Behavioral: Control-training (morning);   Behavioral: Alc-IT (50/50) (afternoon);   Behavioral: Alc-IT (75/25) (afternoon);   Behavioral: Control-training (afternoon)
    Sponsors:   University of Bern;   Clinic Südhang;   Forel Clinic
    Not yet recruiting - verified November 2016

  • Condition:   Alcoholism
    Interventions:   Drug: Doxazosin;   Other: Placebo
    Sponsors:   University of Wisconsin, Madison;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified December 2016

  • Conditions:   Alcohol Use;   Alcohol Drinking;   Drinking Behavior
    Interventions:   Other: Smartphone breathalyzer device/app use;   Other: BAC estimator app use;   Other: Text messaging procedure
    Sponsors:   University of Florida;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Nalmefene;   Drug: Baclofen;   Drug: Placebo Oral Capsule
    Sponsor:   Prof. Daniele Zullino
    Recruiting - verified January 2017

  • Conditions:   Post Traumatic Stress Disorder (PTSD);   Addiction;   Alcohol Abuse
    Interventions:   Drug: N-Acetylcysteine (NAC) Treatment;   Behavioral: Cognitive Behavioral Therapy;   Drug: Placebo Oral Capsule
    Sponsors:   Medical University of South Carolina;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institutes of Health (NIH)
    Recruiting - verified October 2016

  • Conditions:   Condomless Sex;   Human Immunodeficiency Virus (HIV);   Sexually Transmitted Infections (STIs);   Alcohol and Drug Use;   Violence and Victimization;   Access and Linkage to Healthcare;   Education Advancement
    Interventions:   Behavioral: Young Women's Health CoOp (YWHC);   Behavioral: Standard HTC
    Sponsors:   RTI International;   Medical Research Council, South Africa
    Recruiting - verified November 2016

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Saracatinib;   Drug: Placebos
    Sponsor:   Yale University
    Not yet recruiting - verified November 2016

  • Condition:   Alcohol Drinking in College
    Intervention:   Behavioral: Brief Tablet-based Intervention to Address Heavy Alcohol Use
    Sponsor:   Wayne State University
    Recruiting - verified January 2017

  • Condition:   Alcoholic Intoxication
    Interventions:   Behavioral: Implementation of WayToServe Español;   Behavioral: Usual and Customary RBS Training
    Sponsors:   Klein Buendel, Inc.;   University of New Mexico;   University of Texas, El Paso
    Not yet recruiting - verified December 2016

  • Conditions:   Condomless Sex;   Human Immunodeficiency Virus (HIV);   Sexually Transmitted Infection (STI);   Linkage to Care;   Alcohol and Drug Use
    Interventions:   Behavioral: Face-to-Face Women's CoOperative (WC);   Behavioral: mHealth Women's CoOperative (WC);   Behavioral: HIV Counseling and Testing
    Sponsors:   RTI International;   Durham County Department of Public Health;   Guilford County Department of Public Health;   Wake County Human Services
    Recruiting - verified February 2017

  • Condition:   Alcohol Dependence
    Interventions:   Device: medial prefrontal cortex;   Device: dorsolateral prefrontal cortex;   Device: sham stimulation
    Sponsor:   Medical University of South Carolina
    Recruiting - verified October 2016

  • Condition:   Alcoholism
    Interventions:   Drug: Prazosin;   Drug: Placebo
    Sponsors:   University of Wisconsin, Madison;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 2016

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Tolcapone;   Drug: Placebo
    Sponsors:   Medical University of South Carolina;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified October 2016

  • Condition:   Mild to Heavy Alcohol Consumption
    Intervention:   Other: Oxycodone
    Sponsors:   Seattle Institute for Biomedical and Clinical Research;   National Institutes of Health (NIH);   University of Washington;   National Institute on Aging (NIA)
    Recruiting - verified October 2016

  • Conditions:   HIV Positive;   Alcohol Use
    Interventions:   Behavioral: Computerized Brief Intervention (CBI);   Behavioral: CBT4CBT;   Drug: Recommendation and Counseling for Alcohol Pharmacotherapy
    Sponsor:   University of Alabama at Birmingham
    Not yet recruiting - verified October 2016

  • Condition:   Substance Use Disorders
    Interventions:   Behavioral: Critical Dialogue;   Behavioral: Capacity Building Project;   Behavioral: Quality of Life Wheel;   Behavioral: PF;   Behavioral: LC
    Sponsors:   University of Illinois at Urbana-Champaign;   National Development and Research Institutes, Inc.;   Integrity House, Inc.;   University of Michigan;   National Institute on Minority Health and Health Disparities (NIMHD)
    Not yet recruiting - verified October 2016

  • Conditions:   Biofilms;   Substantivity;   Oils, Essential
    Interventions:   Drug: essential oils;   Drug: essential oils without mouthwash;   Drug: sterile water
    Sponsor:   University of Santiago de Compostela
    Not yet recruiting - verified October 2016

  • Condition:   Alcoholic Hepatitis
    Interventions:   Drug: standard medical therapy;   Drug: G-CSF;   Drug: n-Acetylcysteine
    Sponsor:   Postgraduate Institute of Medical Education and Research
    Recruiting - verified November 2016

  • Conditions:   HIV;   Partner Violence;   Malnutrition;   Alcohol Use/Abuse;   Depression
    Interventions:   Behavioral: Accountable Condition;   Behavioral: Control Condition
    Sponsors:   University of California, Los Angeles;   National Institute of Mental Health (NIMH);   University of Stellenbosch
    Not yet recruiting - verified November 2016

  • Condition:   Alcoholism
    Intervention:   Behavioral: Retrieval-Extinction Learning
    Sponsors:   Gabriel Rubio Valladolid, MD;   Hospital Universitario 12 de Octubre;   Instituto de Salud Carlos III
    Recruiting - verified February 2017

  • Condition:   Substance Withdrawal Syndrome
    Interventions:   Other: AUDIT-C;   Other: Smoking history;   Other: Prior psychotropic medication use
    Sponsor:   Seoul National University Hospital
    Recruiting - verified October 2016

  • Condition:   Substance Use
    Interventions:   Behavioral: Intervention Group;   Behavioral: Control Group
    Sponsor:   Shanghai Mental Health Center
    Not yet recruiting - verified October 2016

  • Conditions:   Alcohol Use Disorder;   PTSD;   Cognitive Dysfunction
    Interventions:   Behavioral: Cognitive Training;   Behavioral: Cognitive training placebo control
    Sponsor:   VA Office of Research and Development
    Recruiting - verified October 2016

  • Condition:   Alcohol Dependence
    Intervention:   Other: App Development and Open Pilot
    Sponsors:   Butler Hospital;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 2016

  • Conditions:   Bipolar Disorder;   Alcoholism;   Alcohol Abuse
    Interventions:   Drug: Aripiprazole;   Drug: Placebo
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting - verified November 2016

  • Conditions:   Biofilms;   Oils, Essential;   Periodontitis
    Interventions:   Drug: Essential oils;   Drug: Essential oils without alcohol;   Drug: Sterile water
    Sponsor:   University of Santiago de Compostela
    Not yet recruiting - verified October 2016

  • Condition:   Alcohol Consumption
    Interventions:   Behavioral: Drinking Cognition Feedback (DCF);   Behavioral: Alcohol Risk Feedback (ARF);   Behavioral: Adaptive Goal Support (AGS);   Behavioral: COMBO
    Sponsors:   University of Pittsburgh;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified September 2016

  • Conditions:   Stress Disorders, Post-Traumatic;   Intimate Partner Violence;   Alcohol-Related Disorders
    Intervention:   Behavioral: SHE
    Sponsors:   VISN 17 Center of Excellence;   Brown University;   Women and Infants Hospital of Rhode Island
    Recruiting - verified November 2016

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Zonisamide;   Drug: Placebo
    Sponsor:   Yale University
    Recruiting - verified October 2016

  • Conditions:   Self-regulation;   Adolescents;   Fetal Alcohol Spectrum Disorder
    Intervention:   Behavioral: Self-Regulation Intervention adapted from the Alert Program ®
    Sponsors:   University of Alberta;   Glenrose Rehabilitation Hospital;   Woman and Children's Health Research Institute;   NeuroDevNet
    Not yet recruiting - verified September 2016

  • Conditions:   HIV;   Alcohol Use Disorders
    Intervention:   Other: Transitional HIV care for prison releasees
    Sponsors:   University of North Carolina, Chapel Hill;   National Institutes of Health (NIH);   John E. Fogarty International Center (FIC)
    Not yet recruiting - verified September 2016

  • Condition:   Alcohol Dependance
    Interventions:   Device: medial prefrontal cortex;   Device: dorsolateral prefrontal cortex;   Device: sham
    Sponsors:   Medical University of South Carolina;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified August 2016

  • Conditions:   Alcoholism;   Substance-Related Disorders
    Interventions:   Drug: intranasal oxytocin spray;   Other: intranasal spray without oxytocin
    Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Lade Addiction Treatment Center
    Recruiting - verified February 2017

  • Conditions:   Posttraumatic Stress Disorder (PTSD);   Alcohol Use Disorder (AUD)
    Interventions:   Drug: N-acetylcysteine;   Drug: Placebo;   Behavioral: Cognitive behavioral therapy
    Sponsors:   Medical University of South Carolina;   United States Department of Defense;   Institute for Translational Neuroscience
    Recruiting - verified December 2016

  • Condition:   Alcohol Dependence
    Interventions:   Drug: Zonisamide;   Behavioral: Take Control;   Drug: Placebo (for Zonisamide)
    Sponsors:   Boston University;   Mclean Hospital;   University of Houston
    Not yet recruiting - verified September 2016

  • Conditions:   Alcohol-Related Disorders;   Alcohol Drinking;   Alcoholism;   Alcohol Abuse;   Alcohol Use Disorders
    Interventions:   Behavioral: Motivation Enhacement Therapy;   Behavioral: Motivational Interviewing and Cognitive Behavioral Therapy;   Drug: Naltrexone;   Behavioral: Brief Advice
    Sponsors:   Northwell Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified August 2016

  • Condition:   Alcohol Use Disorder
    Intervention:   Other: the presentation of pictures (static stimuli) or videos (dynamic stimuli)
    Sponsor:   University Hospital, Lille
    Recruiting - verified August 2016

  • Condition:   Catheter-Related Infections
    Interventions:   Other: Ethanol lock;   Other: Heparin lock
    Sponsor:   Stanford University
    Recruiting - verified August 2016

  • Conditions:   PTSD;   Alcohol Use Disorder
    Interventions:   Drug: Pregabalin plus BBCET;   Other: Placebo plus BBCET
    Sponsors:   University of Maryland;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified January 2017

  • Condition:   Alcohol Dependence
    Intervention:  
    Sponsor:   University Hospital, Lille
    Recruiting - verified February 2017

  • Conditions:   Sexual Behavior;   Alcohol Consumption;   Sexually Transmitted Diseases
    Interventions:   Behavioral: Knowledge alone;   Behavioral: Self-efficacy alone;   Behavioral: Perceived benefits alone;   Behavioral: Perceived benefits and self-efficacy;   Behavioral: Injunctive norms;   Behavioral: Injunctive norms and self-efficacy;   Behavioral: Injunctive norms and perceived benefits;   Behavioral: Injunctive norms, perceived benefits, and self-efficacy;   Behavioral: Descriptive norms alone;   Behavioral: Descriptive norms and self-efficacy;   Behavioral: Descriptive norms and perceived benefits;   Behavioral: Descriptive norms,perceived benefits,self-efficacy;   Behavioral: Descriptive and injunctive norms;   Behavioral: Descriptive norms, injunctive norms,self-efficacy;   Behavioral: Descriptive and injunctive norms, benefits;   Behavioral: Descriptive and injunctive norms, benefits,efficacy;   Behavioral: Expectancies alone;   Behavioral: Expectancies and self-efficacy;   Behavioral: Expectancies and Perceived Benefits;   Behavioral: Expectancies, perceived benefits, self-efficacy;   Behavioral: Expectancies and injunctive norms;   Behavioral: Expectancies, injunctive norms, and self-efficacy;   Behavioral: Expectancies, injunctive norms, benefits;   Behavioral: Expectancies, injunctive norms, benefits, efficacy;   Behavioral: Expectancies and descriptive norms;   Behavioral: Expectancies, descriptive norms, and self-efficacy;   Behavioral: Expectancies, descriptive norms, and benefits;   Behavioral: Expectancies,descriptive norms, benefits, efficacy;   Behavioral: Expectancies, descriptive and injunctive norms;   Behavioral: Expectancies, descr& injun norms, efficacy;   Behavioral: Expectancies, desc & injun norms, benefits;   Behavioral: Expectancies,desc & injun norms,benefits,efficacy
    Sponsors:   Penn State University;   University of North Carolina, Greensboro
    Recruiting - verified September 2016

  • Conditions:   Opiate Dependence;   Alcoholism;   Early Satisfaction With Substance Dependence Care
    Intervention:  
    Sponsors:   Central Hospital, Nancy, France;   Hospital of Jury-les-Metz, France;   Healthcare Center of Accompaniment and Prevention in Addictology, Saint-Flour, France
    Recruiting - verified September 2016

  • Conditions:   Hypoglycemia;   Diabetes Mellitus, Type 1
    Interventions:   Dietary Supplement: Alcohol;   Dietary Supplement: Placebo
    Sponsors:   Hvidovre University Hospital;   Danish Diabetes Academy;   University of Copenhagen
    Recruiting - verified December 2016

  • Conditions:   Alcohol Drinking;   Alcohol Intoxication;   Alcoholism
    Intervention:   Device: Brain stimulation with mindfulness-based relapse prevention
    Sponsors:   University of New Mexico;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified January 2017

  • Conditions:   Alcohol Use;   Alcohol Drinking;   Drinking Behavior
    Interventions:   Device: Smartphone breathalyzer device/app use;   Device: BAC estimator app use;   Device: Text messaging procedure
    Sponsor:   University of Florida
    Recruiting - verified December 2016

  • Condition:   Alcohol Use Disorder
    Intervention:   Device: MRI: Brain Imaging data collection
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Not yet recruiting - verified September 2016

  • Conditions:   Alcohol Drinking;   Alcohol Drinking Related Problems
    Interventions:   Behavioral: Retrieval-extinction;   Behavioral: Extinction;   Behavioral: Retrieval
    Sponsor:   National Institute on Drug Abuse (NIDA)
    Not yet recruiting - verified January 24, 2017

  • Condition:   Alcohol Use
    Intervention:   Behavioral: Brief Negotiational Intervention
    Sponsors:   Duke University;   Kilimanjaro Christian Medical Centre, Tanzania;   John E. Fogarty International Center (FIC)
    Not yet recruiting - verified July 2016

  • Condition:   Alcoholic Hepatitis (AH)
    Interventions:   Drug: GS-4997;   Drug: Prednisolone;   Drug: Placebo
    Sponsor:   Gilead Sciences
    Recruiting - verified January 2017

  • Condition:   Alcohol Use
    Interventions:   Behavioral: Smartphone brief intervention (SP-BI);   Other: Enhanced Usual Care (EUC)
    Sponsors:   Joseph Calabrese, MD;   Case Western Reserve University;   University of Michigan;   University of Toledo Health Science Campus
    Not yet recruiting - verified September 2016

  • Conditions:   HIV Infection;   Alcohol Use;   Smoking
    Interventions:   Drug: Varenicline;   Drug: Cytisine;   Drug: Nicotine Replacement Therapy;   Drug: Varenicline Placebo;   Drug: Cytisine Placebo;   Drug: Nicotine Replacement Therapy Placebo
    Sponsors:   Boston Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified December 2016

  • Condition:   Binge Drinking
    Interventions:   Drug: Naltrexone;   Drug: Bupropion
    Sponsors:   University of North Carolina, Chapel Hill;   North Carolina Translational and Clinical Sciences Institute
    Recruiting - verified September 2016

  • Conditions:   Drinking Behavior;   Risky Drinking
    Interventions:   Behavioral: SMI + I;   Behavioral: SMI
    Sponsors:   University of Michigan;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified January 2017

  • Conditions:   Traumatic Brain Injury (TBI);   Hazardous and Harmful Alcohol Use
    Interventions:   Behavioral: Medical Management Counseling;   Drug: N-acetylcysteine;   Drug: Placebo
    Sponsors:   University of California, San Francisco;   United States Department of Defense;   Northern California Institute of Research and Education;   San Francisco Veterans Affairs Medical Center;   Institute for Translational Neuroscience
    Recruiting - verified September 2016

  • Condition:   Liver Cirrhosis, Alcoholic
    Interventions:   Behavioral: Supervised exercise;   Other: Usual Care;   Behavioral: SMS-messages
    Sponsor:   Marius Henriksen
    Recruiting - verified November 2016

  • Conditions:   Domestic Violence;   Mental Health Impairment;   Child Abuse;   Alcoholism
    Interventions:   Behavioral: CATZ/CETA;   Behavioral: Treatment as usual
    Sponsors:   Johns Hopkins Bloomberg School of Public Health;   SHARPZ (Serenity Harm Reduction Programme Zambia)
    Recruiting - verified October 2016

  • Conditions:   Domestic Violence;   Alcohol Consumption
    Interventions:   Drug: Alcohol beverage;   Drug: Placebo beverage
    Sponsors:   University of New Mexico;   The Mind Research Network
    Recruiting - verified January 2017

  • Conditions:   Alcohol Abuse;   Impulsive Behavior
    Interventions:   Drug: Tolcapone;   Drug: Placebo
    Sponsor:   University of California, San Francisco
    Recruiting - verified January 2017

  • Condition:   Nausea
    Interventions:   Drug: Inhaled isopropyl alcohol;   Drug: Oral ondansetron;   Drug: Inhaled normal saline;   Drug: Oral placebo
    Sponsor:   Brooke Army Medical Center
    Recruiting - verified January 2017

  • Condition:   Alcohol Use Disorder
    Interventions:   Behavioral: Individual clinician-provided CBT;   Behavioral: CBT4CBT
    Sponsor:   Yale University
    Recruiting - verified January 2017

  • Conditions:   Alcohol Abuse;   Stress Disorders, Post-Traumatic;   Anxiety Disorders
    Interventions:   Drug: Oxytocin;   Drug: Placebo
    Sponsors:   University of California, San Francisco;   Eisenhower Army Medical Center;   United States Department of Defense;   Congressionally Directed Medical Research Programs
    Not yet recruiting - verified January 2017

  • Condition:   Alcohol Use Disorder
    Intervention:   Drug: Disulfiram
    Sponsor:   New York State Psychiatric Institute
    Recruiting - verified September 2016

  • Condition:   HIV Infection
    Interventions:   Other: ART initiation at time of HIV diagnosis;   Other: ART at 24 weeks post-diagnosis
    Sponsors:   Fred Hutchinson Cancer Research Center;   University of California, San Francisco;   University of Washington;   Asociación Civil Impacta Salud y Educación, Peru;   Université de Montréal;   Seattle Children's Hospital
    Not yet recruiting - verified October 2016

  • Condition:   Ethanol Concentration
    Intervention:   Device: Alcomed 3011®
    Sponsor:   University Hospital Inselspital, Berne
    Recruiting - verified February 2017

  • Conditions:   Alcohol Drinking;   HIV
    Interventions:   Behavioral: Brief Intervention;   Behavioral: Motivational Enhancement Therapy (MET) Intervention;   Behavioral: Cognitive Behavioral Therapy (CBT) Intervention
    Sponsors:   University of North Carolina, Chapel Hill;   National Institute on Drug Abuse (NIDA);   Thai Nguyen Center for Preventive Medicine;   Johns Hopkins University
    Recruiting - verified November 2016

  • Condition:   Alcoholism
    Interventions:   Drug: Oxytocin;   Other: Placebo
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting - verified June 10, 2016

  • Conditions:   Depressive Disorders;   Alcohol Use Disorders
    Interventions:   Other: Usual Care;   Other: Blended Telemedicine-Based Integrated Care
    Sponsor:   VA Office of Research and Development
    Not yet recruiting - verified October 2016

  • Conditions:   Alcohol Drinking;   HIV
    Interventions:   Behavioral: Motivational intervention;   Behavioral: Brief Advice;   Behavioral: Interactive text messaging
    Sponsor:   Brown University
    Recruiting - verified September 2016

  • Conditions:   Cannabis;   Alcohol Effect;   Driving Under the Influence of Alcohol and Other Drugs
    Interventions:   Drug: Active inhaled delta-9-THC;   Drug: Placebo;   Drug: Placebo;   Drug: Active Oral Ethanol
    Sponsor:   Yale University
    Recruiting - verified January 2017

  • Conditions:   Cannabis;   Alcohol Effect;   Driving Under the Influence of Alcohol and Other Drugs
    Interventions:   Drug: Active Dronabinol;   Drug: Placebo;   Drug: Placebo;   Drug: Active Ethanol
    Sponsor:   Yale University
    Recruiting - verified January 2017

  • Conditions:   Parenting;   Alcohol Drinking
    Intervention:   Behavioral: eParenting
    Sponsors:   Michael J. Mello, MD, MPH;   Connecticut Children's Medical Center;   Children's Hospital of Pittsburgh
    Recruiting - verified October 2016

  • Condition:   Alcohol Dependence
    Interventions:   Behavioral: LPA+Fitbit;   Behavioral: HEC
    Sponsors:   Butler Hospital;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified February 2017

  • Condition:   Alcoholism
    Interventions:   Drug: BACLOFEN;   Drug: PLACEBO
    Sponsor:   Nantes University Hospital
    Recruiting - verified January 2017

  • Condition:   Alcoholism
    Interventions:   Drug: PF-05190457;   Behavioral: MI-VF;   Other: Placebo;   Other: Counseling
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 29, 2016

  • Condition:   Alcoholism
    Intervention:  
    Sponsors:   Charite University, Berlin, Germany;   Central Institute of Mental Health, Mannheim
    Recruiting - verified September 2016

  • Conditions:   Nicotine Dependence;   Alcohol Use Disorder
    Interventions:   Drug: Varenicline;   Drug: Varenicline plus Naltrexone
    Sponsors:   University of California, Los Angeles;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified January 2017

  • Condition:   Alcohol Abuse
    Interventions:   Behavioral: ACHESS;   Behavioral: TMC
    Sponsor:   University of Pennsylvania
    Recruiting - verified September 2016

  • Condition:   Psychomotor Impairment
    Interventions:   Drug: Alcohol;   Drug: Placebo
    Sponsors:   Centre for Addiction and Mental Health;   Ontario Ministry of Transportation
    Recruiting - verified September 2016

  • Conditions:   Pain;   Opiates;   Alcohol Drinking
    Interventions:   Behavioral: Prevention Intervention;   Behavioral: Brief Intervention
    Sponsors:   University of Pennsylvania;   United States Department of Defense;   Corporal Michael J. Crescenz VA Medical Center;   Medical University of South Carolina;   VA Pittsburgh Healthcare System
    Recruiting - verified September 2016

  • Conditions:   Alcohol Abuse;   Alcohol Dependence;   Harmful Alcohol Use;   Alcohol Use Disorder
    Intervention:   Behavioral: Guide to better alcohol habits
    Sponsors:   Karolinska Institutet;   Stockholm County Council, Sweden
    Recruiting - verified August 2016

  • Conditions:   Cardiovascular Disease (CVD);   Hypertension;   Hyperlipemia;   Obesity
    Intervention:   Other: Community-based peer health coach intervention
    Sponsor:   VA Office of Research and Development
    Not yet recruiting - verified January 2017

  • Condition:   Alcohol Use Disorders
    Intervention:   Behavioral: Guide to better alcohol habits
    Sponsors:   Karolinska Institutet;   Stockholm County Council, Sweden
    Recruiting - verified August 2016

  • Condition:   Alcohol Consumption
    Interventions:   Drug: Placebo;   Drug: 10 mg Obeticholic Acid (OCA)
    Sponsors:   Suthat Liangpunsakul;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Intercept Pharmaceuticals
    Recruiting - verified April 2016

  • Condition:   Primary Alcohol Use Disorder
    Interventions:   Drug: Ketamine;   Drug: Placebo;   Behavioral: Psychological Therapy;   Behavioral: Alcohol Education
    Sponsor:   University College, London
    Recruiting - verified September 2016

  • Condition:   Alcohol Use Disorders
    Interventions:   Behavioral: Extended self-help program with guidance;   Behavioral: Briefer Self-help program, no guidance;   Behavioral: Waiting list: Extended self-help program with choice of guidance intensity
    Sponsors:   Karolinska Institutet;   Göteborg University
    Recruiting - verified August 2016

  • Conditions:   Healthy Controls;   Alcohol Use Disorder
    Interventions:   Drug: Placebo;   Drug: Oxytocin
    Sponsor:   University of Utah
    Recruiting - verified December 2016

  • Conditions:   Hypertension Resistant to Conventional Therapy;   Kidney Failure, Chronic
    Interventions:   Procedure: Renal sympathicolysis;   Procedure: Ambulatory Blood Pressure Monitoring;   Radiation: Magnetic Resonance Angiography;   Biological: Blood test
    Sponsor:   University Hospital, Grenoble
    Recruiting - verified February 2017

  • Condition:   Alcohol Drinking
    Interventions:   Behavioral: AUDIT brief intervention;   Other: Pamphlet on alcohol use
    Sponsor:   Pontificia Universidad Catolica de Chile
    Recruiting - verified October 2016

  • Conditions:   Coronary; Ischemic;   Arrhythmias, Cardiac;   Heart Failure;   Peripheral Vascular Diseases;   Dementia;   Stroke;   Pulmonary Disease, Chronic Obstructive;   Respiratory Insufficiency;   Alcoholism;   Cancer;   Diabetes;   Renal Insufficiency
    Interventions:   Procedure: OPTI-AGED;   Procedure: Usual Care
    Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
    Not yet recruiting - verified January 2017

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Nalmefene;   Other: Placebo
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified January 25, 2017

  • Condition:   Alcoholic Hepatitis
    Intervention:   Drug: F-652
    Sponsors:   Mayo Clinic;   Indiana University;   Virginia Commonwealth University;   Hennepin County Medical Center, Minneapolis
    Recruiting - verified November 2016

  • Condition:   Alcohol Abuse, Alcohol Dependence
    Interventions:   Behavioral: RBIRT;   Behavioral: SBIRT
    Sponsors:   Polaris Health Directions;   University of Massachusetts, Worcester
    Not yet recruiting - verified November 2015

  • Condition:   Nausea
    Interventions:   Drug: IPA;   Drug: Ondansetron
    Sponsor:   The University of Texas Health Science Center at San Antonio
    Recruiting - verified October 2016

  • Condition:   Acute Alcoholic Hepatitis
    Interventions:   Biological: ELAD System;   Other: Standard of Care (Control)
    Sponsor:   Vital Therapies, Inc.
    Recruiting - verified February 2017

  • Condition:   Fetal Alcohol Syndrome
    Intervention:  
    Sponsor:   Northwestern University
    Recruiting - verified November 2016

  • Condition:   Alcohol Use Disorder
    Intervention:   Drug: Baclofen
    Sponsors:   University Hospital, Lille;   Région Nord-Pas de Calais, France;   Groupement Interrégional de Recherche Clinique et d'Innovation
    Recruiting - verified December 2016

  • Condition:   Alcohol Use Disorder
    Interventions:   Behavioral: AABM Training;   Behavioral: Sham Training
    Sponsors:   University of California, San Francisco;   Brain & Behavior Research Foundation
    Recruiting - verified December 2016

  • Conditions:   Depression;   Alcoholism;   Drug Abuse
    Interventions:   Behavioral: Interpersonal and Social Rhythm Therapy (ISRT);   Behavioral: Bipolar-Specific Cognitive Behavioral Therapy (CBT);   Behavioral: Mindfulness-Based Stress Reduction (MBSR);   Behavioral: Psycho-education & Understanding Bipolar Medications Therapy
    Sponsor:   Emory University
    Recruiting - verified November 2016

  • Conditions:   Alcohol Use Disorder;   Bipolar Disorder
    Interventions:   Drug: Placebo;   Drug: Citicoline;   Drug: Pregnenolone
    Sponsors:   University of Texas Southwestern Medical Center;   University of Miami
    Recruiting - verified February 2017

  • Conditions:   Alcohol Consumption;   HIV;   Motivation
    Interventions:   Behavioral: Motivational Interviewing;   Other: Questionnaire assessment;   Other: Neurocognitive assessments;   Other: Blood specimens
    Sponsors:   University of Florida;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Condition:   Alcohol Dependence
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified October 12, 2016

  • Condition:   Substance Use Disorder
    Interventions:   Behavioral: Resonance Breathing;   Behavioral: Non-Resonance Breathing
    Sponsors:   Rutgers, The State University of New Jersey;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 2016

  • Conditions:   Cerebral Blood Flow;   Metabolism;   Gut Microbiome
    Interventions:   Drug: acetate;   Drug: alcohol
    Sponsor:   University of Colorado, Denver
    Recruiting - verified November 2016

  • Condition:   Alcohol Dependence
    Interventions:   Drug: CI-581a;   Drug: CI-581b;   Behavioral: Motivational Enhancement Therapy (MET)
    Sponsors:   New York State Psychiatric Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified October 2016

  • Condition:   Adolescent Behavior
    Interventions:   Behavioral: Sexual Health;   Behavioral: Alcohol Prevention;   Behavioral: Teen Driving
    Sponsor:   Children's Hospital of Philadelphia
    Recruiting - verified December 2016

  • Condition:   Binge Drinking
    Interventions:   Dietary Supplement: Probiotic;   Dietary Supplement: Placebo;   Dietary Supplement: Alcohol
    Sponsor:   Medical University of Graz
    Not yet recruiting - verified November 2016

  • Conditions:   Nonorganic Insomnia;   Neurodevelopmental Disorders;   Primary Insomnia
    Intervention:   Behavioral: BNBD-NDD Intervention
    Sponsor:   IWK Health Centre
    Not yet recruiting - verified September 2016

  • Conditions:   Posttraumatic Stress Disorder;   Alcohol Use Disorders
    Interventions:   Drug: doxazosin xL;   Drug: placebo
    Sponsors:   VA Office of Research and Development;   Medical University of South Carolina;   Consortium to Alleviate PTSD
    Recruiting - verified January 2017

  • Conditions:   Alcohol-Related Disorders;   Alcohol Use Disorders;   Alcohol Drinking;   Alcoholism;   Alcohol Abuse
    Interventions:   Behavioral: Brief Advice;   Behavioral: Motivational Interviewing;   Behavioral: Behavioral Self-Control Training
    Sponsors:   Northwell Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Condition:   Alcohol Dependence
    Intervention:   Drug: Nalmefene
    Sponsors:   University of Bordeaux;   Lundbeck France
    Recruiting - verified October 2016

  • Conditions:   Unhealthy Alcohol Use;   Alcohol Use Disorders
    Intervention:  
    Sponsor:   University of Colorado, Denver
    Recruiting - verified August 2016

  • Conditions:   Hypertension;   Diabetes;   Depression;   Alcohol Use Disorder
    Interventions:   Other: mWELLCARE;   Other: Usual Care
    Sponsors:   Public Health Foundation of India;   Wellcome Trust;   London School of Hygiene and Tropical Medicine
    Recruiting - verified August 2016

  • Condition:   Alcohol Abuse
    Intervention:   Behavioral: Youth Access
    Sponsor:   Oregon Research Institute
    Recruiting - verified September 2016

  • Conditions:   Fear;   Stress;   Alcohol Dependence
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 28, 2016

  • Conditions:   Alcoholism;   Alcohol Related Disorders
    Interventions:   Drug: oxytocin;   Drug: placebo
    Sponsor:   Johns Hopkins University
    Recruiting - verified August 2016

  • Conditions:   Suicide;   Alcohol Drinking
    Intervention:   Behavioral: motivational enhancement therapy
    Sponsors:   Boston Children’s Hospital;   American Foundation for Suicide Prevention
    Recruiting - verified December 2016

  • Condition:   Alcoholism
    Interventions:   Behavioral: Motivational Enhancement Therapy;   Behavioral: Cognitive Behavioral Therapy;   Other: FC Assessment;   Other: IB Assessment
    Sponsors:   Rutgers, The State University of New Jersey;   Syracuse University;   Pacific Institute for Research and Evaluation;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Conditions:   Cannabis;   Alcohol Effect;   Driving Under the Influence of Alcohol and Other Drugs
    Interventions:   Drug: Active delta-9-THC;   Drug: Placebo;   Drug: Active Ethanol;   Drug: Placebo
    Sponsor:   Yale University
    Recruiting - verified January 2017

  • Conditions:   HIV;   Alcohol Use;   Medication Adherence
    Interventions:   Behavioral: PLUS intervention;   Behavioral: Enhanced treatment as usual (eTAU) wait-list condition
    Sponsors:   Hunter College of City University of New York;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified October 2016

  • Conditions:   Major Depression;   Alzheimer's Disease;   Alcoholism;   Schizophrenia
    Intervention:  
    Sponsor:   Charite University, Berlin, Germany
    Recruiting - verified November 2016

  • Conditions:   Alcohol Abuse;   Alcohol Dependence;   Harmful Alcohol Use;   Alcohol Use Disorder
    Interventions:   Behavioral: Alkoholhjälpen counselor support;   Behavioral: eChange Alkoholhjälpen;   Behavioral: Alkoholhjälpen
    Sponsors:   Karolinska Institutet;   Public Health Agency of Sweden;   Center for Psychiatry Research
    Recruiting - verified August 2016

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Zonisamide;   Drug: Placebo
    Sponsor:   VA Office of Research and Development
    Recruiting - verified September 2016

  • Condition:   Bariatric Surgery Candidate
    Intervention:   Other: Alcohol
    Sponsors:   Neuropsychiatric Research Institute, Fargo, North Dakota;   University of Kentucky;   Kent State University;   North Dakota State University
    Recruiting - verified September 2016

  • Conditions:   Alcoholism;   Attention Deficit Disorder With Hyperactivity
    Intervention:   Behavioral: cognitive and psychiatric assessment
    Sponsors:   University Hospital, Lille;   Institute for Scientific Research on Beverages (France)
    Recruiting - verified February 2017

  • Condition:   Alcoholism
    Interventions:   Other: Computerized Alcohol Misuse Intervention;   Other: Attention Control (AC)
    Sponsors:   Research Circle Associates, LLC;   University of Maryland, Baltimore County;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 2016

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Ondansetron;   Drug: Placebo
    Sponsors:   University of Maryland;   University of Pennsylvania
    Recruiting - verified December 2016

  • Conditions:   Alcohol Use Disorder;   Alcohol Withdrawal
    Interventions:   Drug: Gabapentin;   Drug: Placebo
    Sponsor:   Medical University of South Carolina
    Recruiting - verified October 2016

  • Conditions:   Binge Drinking;   HIV
    Interventions:   Drug: Placebo;   Drug: Naltrexone
    Sponsors:   University of California, San Francisco;   San Francisco Department of Public Health;   National Institutes of Health (NIH)
    Recruiting - verified September 2016

  • Condition:   Alcoholism
    Interventions:   Drug: Topiramate;   Behavioral: Medical Management;   Drug: Inactive Placebo
    Sponsors:   University of Pennsylvania;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institutes of Health (NIH);   Department of Health and Human Services;   Corporal Michael J. Crescenz VA Medical Center
    Recruiting - verified October 2016

  • Conditions:   Human Immunodeficiency Virus;   HBV;   Fibrosis, Liver;   Cirrhosis, Liver;   Hepatocellular Carcinoma;   Hepatitis Delta Virus;   Alcoholic Hepatitis
    Intervention:   Drug: Anti-HIV Agents
    Sponsors:   University of North Carolina, Chapel Hill;   John E. Fogarty International Center (FIC);   National Institutes of Health (NIH)
    Recruiting - verified September 2016

  • Conditions:   Alcohol Use Disorder;   PTSD
    Interventions:   Drug: Prazosin;   Drug: Naltrexone;   Drug: Placebo;   Drug: Placebo
    Sponsors:   Seattle Institute for Biomedical and Clinical Research;   United States Department of Defense;   VA Puget Sound Health Care System
    Recruiting - verified December 2016

  • Condition:   Alcoholism
    Intervention:   Behavioral: Cognitive Behavioral Coping Skills Therapy
    Sponsor:   New York State Psychiatric Institute
    Recruiting - verified September 2016

  • Condition:   Risk Reduction Behavior
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified October 27, 2016

  • Conditions:   Infection;   Alcohol Abuse;   Drugs of Abuse;   Lung Injury
    Intervention:   Other: Characterize alcohol and drug use
    Sponsors:   University of Colorado, Denver;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Condition:   Infants of Diabetic Mothers
    Intervention:   Other: N/A - No intervention
    Sponsor:   University of Oklahoma
    Recruiting - verified November 2016

  • Conditions:   Substance-Related Disorders;   Human Immunodeficiency Virus;   Alcoholism
    Interventions:   Behavioral: Soccer League (SL);   Behavioral: Soccer League/Vocational Training (SL-V)
    Sponsors:   University of California, Los Angeles;   National Institute on Drug Abuse (NIDA)
    Recruiting - verified August 2016

  • Condition:   Alcohol Use Disorders
    Interventions:   Behavioral: Intensive Motivational Interviewing;   Behavioral: Single session of Motivational Interviewing
    Sponsor:   Public Health Institute, California
    Recruiting - verified September 2016

  • Condition:   Hepatitis
    Intervention:  
    Sponsor:   Basildon and Thurrock University Hospitals NHS Foundation Trust
    Recruiting - verified December 2016

  • Conditions:   Alcoholic Hepatitis;   Alcoholic Liver Disease
    Interventions:   Drug: Amoxicillin;   Drug: Placebo;   Drug: Prednisolone
    Sponsors:   University Hospital, Lille;   Ministry of Health, France
    Recruiting - verified October 2016

  • Condition:   Alcohol Use Disorders (AUD)
    Intervention:   Drug: Mifepristone 600-mg/day or placebo for a week
    Sponsor:   Brown University
    Recruiting - verified February 2017

  • Condition:   Alcoholism
    Interventions:   Drug: 125 mg AZD0530;   Drug: 50 mg AZD0530;   Drug: Placebo
    Sponsor:   Yale University
    Recruiting - verified November 2016

  • Condition:   Alcohol Abuse
    Interventions:   Behavioral: Brief Negotiated Interview;   Behavioral: General Health Information
    Sponsors:   University of North Carolina, Chapel Hill;   The American Geriatrics Society;   National Institute on Aging (NIA);   Society for Academic Emergency Medicine;   North Carolina Translational and Clinical Sciences Institute
    Recruiting - verified February 2017

  • Conditions:   AOD Use, Abuse, and Dependence;   Depression
    Interventions:   Behavioral: MET/CBT-12;   Behavioral: CBT-D;   Other: D-TAU
    Sponsors:   Duke University;   UConn Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified June 2016

  • Condition:   Alcoholism
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 22, 2016

  • Condition:   Alcoholism
    Interventions:   Device: MRI;   Drug: C-11PBR28;   Drug: F-18FDG
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified January 19, 2017

  • Conditions:   Alcoholism;   Substance-related Disorders;   Dual Diagnosis
    Interventions:   Behavioral: Group Motivational Interviewing (GMI);   Behavioral: Control Treatment Condition (CT)
    Sponsor:   VA Office of Research and Development
    Recruiting - verified December 2016

  • Condition:   Co-Occurring Alcohol and Drug Misuse
    Interventions:   Behavioral: CM for Alcohol;   Behavioral: CM for drugs;   Behavioral: CM for both substances;   Behavioral: Non-Contingent group
    Sponsor:   Washington State University
    Recruiting - verified September 2016

  • Conditions:   Alcohol Use Disorders;   Stress Disorders, Posttraumatic;   Combat Disorders
    Interventions:   Drug: prazosin hydrochloride;   Drug: placebo
    Sponsors:   Seattle Institute for Biomedical and Clinical Research;   United States Department of Defense;   VA Puget Sound Health Care System
    Recruiting - verified October 2016

  • Conditions:   Alcohol Dependence;   Post-Traumatic Stress Disorder (PTSD)
    Interventions:   Drug: Progesterone;   Drug: Placebo (for Progesterone)
    Sponsors:   Yale University;   United States Department of Defense
    Recruiting - verified November 2016

  • Conditions:   Alcohol Dependence;   Alcohol Use Disorders;   Alcohol Abuse;   Alcoholism
    Interventions:   Drug: Mifepristone 1200 mg daily;   Behavioral: Standardized behavioral therapy;   Drug: Mifepristone 600 mg daily;   Drug: Placebo
    Sponsors:   The Scripps Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Condition:   Hepatitis C, Chronic; AUD
    Interventions:   Behavioral: Brief alcohol counseling;   Behavioral: Group and Individual Therapy Sessions
    Sponsors:   Duke University;   University of North Carolina, Chapel Hill;   Durham VA Medical Center
    Recruiting - verified November 2016

  • Conditions:   Depression;   Anxiety;   Alcohol Abuse;   Tobacco Abuse
    Intervention:   Behavioral: Savings program
    Sponsor:   Stanford University
    Recruiting - verified October 2016

  • Conditions:   Alcohol Use Disorder;   Eligible to go Into the MRI Scanner;   Short-term Abstinence From Alcohol Use (2 Week Abstinent)
    Intervention:   Device: Transcranial Direct Current Stimulation (tDCS)
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Recruiting - verified September 2016

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Guanfacine 3mg/day;   Drug: Guanfacine 1.5mg/day;   Drug: Placebo
    Sponsors:   Yale University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 2016

  • Conditions:   Nicotine Dependence;   Cigarette Smoking;   Alcohol Consumption;   Heavy Drinking
    Intervention:   Drug: Varenicline
    Sponsor:   Yale University
    Recruiting - verified December 2016

  • Condition:   Alcoholic Hepatitis
    Intervention:  
    Sponsors:   Indiana University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 2016

  • Condition:   Obesity
    Intervention:  
    Sponsor:   University of Missouri-Columbia
    Recruiting - verified November 2016

  • Conditions:   Magnetic Resonance Imaging;   Major Depression;   Alcoholism
    Interventions:   Drug: Ketamine;   Other: Alcohol Infusion
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting - verified November 22, 2016

  • Conditions:   Alcohol Dependence;   Alcohol Drinking;   Alcoholism
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 30, 2016

  • Conditions:   Alcohol Dependence;   Alcohol Drinking;   Alcohol-Related Disorders;   Alcoholism;   Brain Mapping
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 29, 2016

  • Conditions:   Alcoholism;   fMRI;   Rewarding Mediating System
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 1, 2016

  • Conditions:   Evaluating NIAAA's Alcohol Screener;   Evaluating a Brief Intervention
    Interventions:   Behavioral: Brief Intervention;   Behavioral: Brief Intervention with Coaching;   Behavioral: Treatment as Usual
    Sponsors:   University of Rhode Island;   Brown University
    Recruiting - verified December 2016

  • Conditions:   Drug Addiction;   Executive Dysfunction
    Intervention:   Device: transcranial Direct Current Stimulation
    Sponsors:   Federal University of Espirito Santo;   Conselho Nacional de Desenvolvimento Científico e Tecnológico;   Harvard Medical School;   University of Göttingen
    Recruiting - verified February 2017

  • Conditions:   Alcohol Use Disorder;   Contingency Management
    Interventions:   Behavioral: Prize Contingency Management for Alcohol Abstinence;   Behavioral: Standard Care
    Sponsors:   UConn Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Conditions:   Alcohol Use Disorder;   Contingency Management
    Interventions:   Behavioral: prize contingency management for attending treatment;   Behavioral: usual care;   Device: The Secure Continuous Remote Alcohol Monitor (SCRAMx®)
    Sponsors:   UConn Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Topiramate;   Drug: Placebo
    Sponsor:   University of Pennsylvania
    Recruiting - verified August 2016

  • Condition:   Alcoholic Hepatitis
    Intervention:  
    Sponsors:   University of North Carolina, Chapel Hill;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   University of Wisconsin, Madison;   King's College London;   Veterans Medical Research Foundation;   Universidad Autonoma de Nuevo Leon;   Hospital Vall d'Hebron
    Recruiting - verified September 2016

  • Conditions:   Unhealthy Alcohol Use;   Alcohol Use Disorder;   Alcohol Disorders
    Intervention:   Behavioral: Relational Agent Intervention
    Sponsors:   VA Office of Research and Development;   Northeastern University;   Boston University;   Brown University
    Recruiting - verified October 2016

  • Condition:   Alcoholic Hepatitis
    Interventions:   Drug: Placebo;   Drug: 10 mg Obeticholic Acid (OCA)
    Sponsors:   Naga P. Chalasani;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Intercept Pharmaceuticals
    Recruiting - verified February 2017

  • Condition:   Alcohol Use Disorder
    Interventions:   Behavioral: Bias retraining;   Behavioral: Sham retraining
    Sponsors:   University of Michigan;   National Institute on Drug Abuse (NIDA);   University of Maryland
    Recruiting - verified October 2016

  • Condition:   Alcoholism
    Interventions:   Drug: Baclofen;   Drug: Placebo
    Sponsor:   University of North Carolina, Chapel Hill
    Recruiting - verified September 2016

  • Condition:   HIV
    Intervention:   Behavioral: Motivational Enhancement Therapy (MET)
    Sponsors:   Wayne State University;   Westat;   City University of New York, School of Public Health;   University of California, San Diego;   Medical University of South Carolina;   University of California, Los Angeles;   Columbia University;   University of Alabama at Birmingham
    Recruiting - verified January 2017

  • Condition:   Alcohol Dependence
    Interventions:   Drug: XR-NTX+HRC;   Other: Placebo+HRC;   Behavioral: HRC
    Sponsors:   University of Washington;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Alkermes, Inc.
    Recruiting - verified October 2016

  • Condition:   Hepatitis, Alcoholic
    Interventions:   Drug: IMM 124-E (Hyperimmune Bovine Colostrum);   Drug: Placebo (High protein milk powder)
    Sponsors:   Virginia Commonwealth University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Immuron Ltd.
    Recruiting - verified August 2016

  • Condition:   Alcohol Dependence
    Interventions:   Drug: XR-NTX (Extended-Release Naltrexone);   Drug: Oral Naltrexone (O-NTX)
    Sponsor:   New York University School of Medicine
    Recruiting - verified November 2016

  • Condition:   Alcoholism
    Interventions:   Procedure: Bronchoscopy;   Dietary Supplement: Zinc sulfate 220 mg once daily;   Dietary Supplement: S-adenosylmethionine 400 mg twice daily
    Sponsor:   VA Office of Research and Development
    Recruiting - verified December 2016

  • Conditions:   Alcohol Abuse;   Tobacco Use Disorder;   Substance Use
    Intervention:   Behavioral: cMET
    Sponsor:   Boston Children’s Hospital
    Recruiting - verified October 2016

  • Conditions:   Ventricular Tachycardia;   Atrial Fibrillation
    Interventions:   Drug: Ethanol;   Procedure: Ablation
    Sponsors:   Miguel X. Valderrabano, MD;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI);   The Methodist Hospital System
    Recruiting - verified September 2016

  • Condition:   Obesity
    Interventions:   Other: Alcohol challenge test Alcohol visit first;   Other: Alcohol challenge test Placebo visit first
    Sponsors:   University of Illinois at Urbana-Champaign;   University of Missouri-Columbia;   Washington University School of Medicine
    Recruiting - verified January 2017

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated
    Recruiting - verified September 2016

  • Condition:   Alcohol Dependence
    Interventions:   Drug: GET 73;   Drug: inactive ingredients capsule
    Sponsors:   Laboratorio Farmaceutico Ct S.r.l.;   Voisin Consulting, Inc.;   Latis Srl;   Quotient Bioresearch Ltd
    Recruiting - verified September 2016

  • Conditions:   Alcoholism;   Alcohol Abuse;   Alcohol Dependence
    Interventions:   Drug: Dutasteride;   Drug: sugar pill
    Sponsors:   UConn Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified October 2016

  • Conditions:   Alcohol Dependence;   Posttraumatic Stress Disorder (PTSD)
    Interventions:   Drug: Topiramate;   Drug: placebo
    Sponsors:   University of California, San Francisco;   United States Department of Defense;   San Francisco Veterans Affairs Medical Center;   Northern California Institute of Research and Education
    Recruiting - verified October 2016

  • Conditions:   Hepatitis C;   Alcohol Abuse
    Interventions:   Other: Web-Based Brief Alcohol Intervention;   Other: Usual Care
    Sponsor:   VA Office of Research and Development
    Recruiting - verified September 2016

  • Conditions:   PTSD;   Alcohol Abuse;   Alcohol Dependence
    Interventions:   Behavioral: Cognitive Processing Therapy (CPT);   Behavioral: Relapse Prevention (RP)
    Sponsors:   University of Washington;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 2016

  • Condition:   Alcohol Dependence
    Intervention:   Drug: citalopram
    Sponsor:   VA Office of Research and Development
    Recruiting - verified October 2016

  • Conditions:   Dating Violence;   Dating Abuse
    Intervention:   Behavioral: Real Talk Intervention
    Sponsors:   Boston University;   U.S. Department of Justice
    Recruiting - verified December 2016

  • Conditions:   Schizophrenia;   Cannabis Dependence;   Prodromal for Psychotic Illness;   Family History of Alcoholism
    Intervention:   Radiation: [11-C]OMAR
    Sponsors:   Yale University;   National Institute on Drug Abuse (NIDA);   National Institute of Mental Health (NIMH)
    Recruiting - verified December 2016

  • Condition:   Congenital Malformation
    Intervention:   Other: meconium samples + maternal self-questionnaire
    Sponsor:   Rennes University Hospital
    Recruiting - verified January 2017

  • Conditions:   Active Ethanol and Active Iomazenil;   Active Ethanol and Placebo Iomazenil;   Placebo Ethanol and Placebo Iomazenil;   Placebo Ethanol and Active Iomazenil
    Interventions:   Drug: Ethanol;   Drug: Iomazenil
    Sponsor:   VA Office of Research and Development
    Recruiting - verified December 2016

  • Conditions:   PTSD;   Alcoholism
    Interventions:   Behavioral: Integrated Prolonged Exposure Therapy;   Behavioral: Seeking Safety
    Sponsor:   VA Office of Research and Development
    Recruiting - verified September 2016

  • Conditions:   Cushing's Syndrome;   Adrenal Incidentalomas;   Alcoholism;   Obesity
    Intervention:  
    Sponsor:   Haukeland University Hospital
    Recruiting - verified September 2016

  • Condition:   Alcohol Abuse
    Intervention:   Behavioral: Group Brief Alcohol Intervention
    Sponsors:   University of Tennessee;   National Cancer Institute (NCI);   University of Minnesota - Clinical and Translational Science Institute;   United States Air Force
    Recruiting - verified October 2016

  • Condition:   Hepatocellular Carcinoma
    Interventions:   Other: Solvent with specific gravity less than lipiodol;   Other: Solvent with specific gravity equivalent to lipiodol
    Sponsor:   Sun Yat-sen University
    Recruiting - verified November 2016

  • Condition:   Hepatocellular Carcinoma
    Interventions:   Other: Embolization;   Other: Infusion of anticancer agent;   Other: Infusion of mixture of anticancer agent and lipiodol
    Sponsor:   Sun Yat-sen University
    Recruiting - verified December 2016

  • Conditions:   Carcinoma, Hepatocellular;   Liver Cirrhosis, Alcoholic;   Hepatitis, Alcoholic;   Hepatitis, Chronic;   Hepatitis, Viral, Human
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified July 14, 2016

  • Condition:   Alcoholic Intoxication
    Interventions:   Drug: Alcohol;   Procedure: Self-Administration
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified December 5, 2016

  • Condition:   Alcohol Dependence
    Interventions:   Drug: Prazosin;   Drug: placebo
    Sponsors:   Yale University;   National Institutes of Health (NIH);   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting - verified November 2016


PaidClinicalTrials.orgPaidClinicalTrials.org